Libramont-Chevigny

Belgium

32 total trials 10 recruiting

Filter these 32 trials by phase, condition, sponsor and more.

Open in Search →

A Study of Lorigerlimab with Docetaxel or Docetaxel Alone in Participants with Metastatic Castration-Resistant Prostate Cancer Ended

2022-502982-49-00 4 2024-07-15 Metastatic Castration-Resistant Prostate Cancer
Phase 1b safety study of xevinapant, weekly cisplatin, and radiotherapy in participants with unresected LA SCCHN Ended

2023-505796-76-00 3 2024-01-18 Locally Advanced Squamous Cell Carcinoma of the Head and Neck
A Phase 2, Randomized, Open-Label Study Evaluating the Safety and Efficacy of Magrolimab in Combination With Bevacizumab and FOLFIRI Versus … Ended

2022-500177-13-00 4 2023-06-02 Metastatic Colorectal Cancer (mCRC)
A Study of Two Dose Levels of Vobramitamab Duocarmazine in Participants with Metastatic Castration-resistant Prostate Cancer (TAMARACK) Ended

2022-501078-20-00 4 2023-05-15 Metastatic Castration-resistant Prostate Cancer
Study to compare overall survival (OS) between subjects who receive SBP-101 and those who do not receive SBP-101 (i.e., placebo) in combinat … Ended

2024-514714-12-00 10 2022-11-11 Metastatic Pancreatic Ductal Adenocarcinoma
Bemarituzumab plus Chemotherapy and Nivolumab versus Chemotherapy and Nivolumab Alone (FORTITUDE-102) Ended

2023-505458-16-00 5 2022-09-13 Gastric and Gastroesophageal Junction Cancer With FGFR2b Overexpressio
Dose Escalation of DF1001 in Patients With Advanced Solid Tumors, and Expansion in Selected Indications Ended

2023-503291-24-00 9 2021-03-17 Locally Advanced or Metastatic Solid Tumors, and Expansion in Selected
First-line chemotherapy plus pembrolizumab and olaparib for BRCA nonmutated advanced EOC Ended

2022-502124-52-00 5 2018-12-18 Advanced epithelial ovarian cancer

Showing 25–32 of 32 trials